Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein Hook homolog 3 (HOOK3) is a member of the Hook family of cytosolic coiled-coil proteins that possess conserved N-terminal domains mediating attachment to microtubules and divergent C-terminal domains responsible for organelle-specific interactions[2][3][4]. HOOK3 localizes mainly to the Golgi complex, participates in Golgi positioning and organization, and acts as a molecular adaptor linking organelles to the microtubule cytoskeleton[2][3]. It also interacts with cargo motors including dynein/dynactin and KIF1C, activating the latter and scaffolding complexes for bidirectional vesicle transport along microtubules[5]. Although HOOK3 has cellular functions critical for intracellular trafficking and organelle architecture, it is not classified as a canonical therapeutic target such as a receptor, enzyme, transporter, or ion channel[2][4][5]. No interacting drugs, mechanisms of action, recognized roles as a biomarker, or direct disease associations have been established in the literature to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Hook homolog 3 (HOOK3).